BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33199729)

  • 41. Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors?
    Patil DT; Rubin BP
    Surg Pathol Clin; 2015 Sep; 8(3):515-24. PubMed ID: 26297068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.
    Miettinen M; Killian JK; Wang ZF; Lasota J; Lau C; Jones L; Walker R; Pineda M; Zhu YJ; Kim SY; Helman L; Meltzer P
    Am J Surg Pathol; 2013 Feb; 37(2):234-40. PubMed ID: 23282968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
    Nishida T; Naito Y; Takahashi T; Saito T; Hisamori S; Manaka D; Ogawa K; Hirota S; Ichikawa H
    Cancer Sci; 2024 Mar; 115(3):894-904. PubMed ID: 38178783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.
    Brenca M; Rossi S; Polano M; Gasparotto D; Zanatta L; Racanelli D; Valori L; Lamon S; Dei Tos AP; Maestro R
    J Pathol; 2016 Mar; 238(4):543-9. PubMed ID: 26606880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.
    Gasparotto D; Rossi S; Polano M; Tamborini E; Lorenzetto E; Sbaraglia M; Mondello A; Massani M; Lamon S; Bracci R; Mandolesi A; Frate E; Stanzial F; Agaj J; Mazzoleni G; Pilotti S; Gronchi A; Dei Tos AP; Maestro R
    Clin Cancer Res; 2017 Jan; 23(1):273-282. PubMed ID: 27390349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
    Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
    Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance.
    Boichuk S; Galembikova A; Dunaev P; Valeeva E; Shagimardanova E; Gusev O; Khaiboullina S
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29206199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
    Gao J; Li J; Li Y; Li Z; Gong J; Wu J; Liu N; Dong B; Qi C; Li J; Shen L
    Oncotarget; 2016 May; 7(21):30241-9. PubMed ID: 26848617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
    Baskin Y; Kocal GC; Kucukzeybek BB; Akbarpour M; Kayacik N; Sagol O; Ellidokuz H; Oztop I
    Oncol Res; 2016; 24(1):41-53. PubMed ID: 27178821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of succinate dehydrogenase subunit protein in succinate dehydrogenase-deficient gastrointestinal stromal tumors].
    Zhang YJ; Cheng YH; Guo LX; Wang NQ; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):252-257. PubMed ID: 29690663
    [No Abstract]   [Full Text] [Related]  

  • 52. Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST.
    Pantaleo MA; Urbini M; Indio V; Ravegnini G; Nannini M; De Luca M; Tarantino G; Angelini S; Gronchi A; Vincenzi B; Grignani G; Colombo C; Fumagalli E; Gatto L; Saponara M; Ianni M; Paterini P; Santini D; Pirini MG; Ceccarelli C; Altimari A; Gruppioni E; Renne SL; Collini P; Stacchiotti S; Brandi G; Casali PG; Pinna AD; Astolfi A; Biasco G
    Mol Cancer Res; 2017 May; 15(5):553-562. PubMed ID: 28130400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
    Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
    Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple sporadic gastrointestinal stromal tumours arising at different gastrointestinal sites: pattern of involvement of the muscularis propria as a clue to independent primary GISTs.
    Agaimy A; Märkl B; Arnholdt H; Wünsch PH; Terracciano LM; Dirnhofer S; Hartmann A; Tornillo L; Bihl MP
    Virchows Arch; 2009 Aug; 455(2):101-8. PubMed ID: 19572146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classification of gastrointestinal stromal tumor syndromes.
    Gopie P; Mei L; Faber AC; Grossman SR; Smith SC; Boikos SA
    Endocr Relat Cancer; 2018 Feb; 25(2):R49-R58. PubMed ID: 29170162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs].
    Kalfusová A; Kodet R
    Cesk Patol; 2017; 53(4):167-173. PubMed ID: 29227120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
    Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
    Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.
    Dwight T; Benn DE; Clarkson A; Vilain R; Lipton L; Robinson BG; Clifton-Bligh RJ; Gill AJ
    Am J Surg Pathol; 2013 Feb; 37(2):226-33. PubMed ID: 23060355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications.
    Lasota J; Wang Z; Kim SY; Helman L; Miettinen M
    Am J Surg Pathol; 2013 Jan; 37(1):114-9. PubMed ID: 22892600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of the molecular heterogeneity of gastrointestinal stromal tumors and related research: A systematic review.
    Ding H; Yu X; Yu Y; Lao X; Hang C; Gao K; Jia Y; Yan Z
    Oncol Rep; 2020 Mar; 43(3):751-764. PubMed ID: 32020209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.